WUXI BIO (02269) announced that it cancelled 39.8245 million repurchased shares on September 18, 2026.
The cancellation involves shares previously bought back by the company as part of its ongoing capital management strategy.
Following the cancellation, the company's total issued share capital will be reduced accordingly, reflecting the latest corporate action.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments